The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β₂-agonists in the United Kingdom: a cross-sectional analysis.

ABSTRACT: There are several new treatment options for patients whose asthma remains uncontrolled on free-dose and fixed-dose combinations of inhaled corticosteroids plus long-acting β₂-agonists (ICS+LABA). In order to evaluate the likely impact of these treatments, we assessed the effect of uncontrolled asthma on healthcare and patient burden within the UK among adult patients treated with ICS+LABA. Data obtained from 2010-2011 UK National Health and Wellness Surveys identified 701 patients treated with ICS+LABA. Patients with not well-controlled asthma (Asthma Control Test™ score <20) were compared with well-controlled asthma (score ≥ 20) patients on multiple measures. Cost burden was calculated using healthcare resource utilisation models and work productivity and impairment questionnai

SUBMITTER: Pavord ID 

PROVIDER: S-EPMC5434793 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature